0001209191-23-043276.txt : 20230725 0001209191-23-043276.hdr.sgml : 20230725 20230725122837 ACCESSION NUMBER: 0001209191-23-043276 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230721 FILED AS OF DATE: 20230725 DATE AS OF CHANGE: 20230725 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: PASSERI DANIEL R CENTRAL INDEX KEY: 0001190121 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38327 FILM NUMBER: 231107619 MAIL ADDRESS: STREET 1: 40 GUEST STREET CITY: BOSTON STATE: MA ZIP: 02135 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Cue Biopharma, Inc. CENTRAL INDEX KEY: 0001645460 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 473324577 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 40 GUEST STREET CITY: BOSTON STATE: MA ZIP: 02135 BUSINESS PHONE: 617-949-2680 MAIL ADDRESS: STREET 1: 40 GUEST STREET CITY: BOSTON STATE: MA ZIP: 02135 FORMER COMPANY: FORMER CONFORMED NAME: Imagen Biopharma, Inc. DATE OF NAME CHANGE: 20150617 4 1 doc4.xml FORM 4 SUBMISSION X0508 4 2023-07-21 0 0001645460 Cue Biopharma, Inc. CUE 0001190121 PASSERI DANIEL R C/O CUE BIOPHARMA, INC. 40 GUEST STREET BOSTON MA 02135 1 1 0 0 CHIEF EXECUTIVE OFFICER 0 Stock Option (right to buy) 4.20 2023-07-21 4 A 0 450000 0.00 A 2033-07-20 Common Stock 450000 450000 D This stock option grant becomes exercisable in twenty four equal monthly installments beginning on August 21, 2023. /s/ Daniel Passeri by Colin Sandercock, attorney-in-fact 2023-07-25